Biocept, Inc. (NASDAQ: BIOC) Surges 66% After Signing Agreements with Prognos, Inc. to Utilize AI Capabilities in Oncology Diagnostics
Biocept, Inc. (NASDAQ: BIOC) is an early-stage molecular oncology diagnostics company. Shares surged 66.28% through early trading on Tuesday, December ...
